ADT Surges 43% in a Week While Peers Slide, Deal Arbitrage Takes Over

ADT gained 43% over the past week while its closest correlated peers fell a median 6.2%, a divergence that has nothing to do with operating momentum and everything to do with the $7.4 billion Thrive Holdings acquisition announced on 29 October.

That gap between ADT and its peer group is the sharpest in the data. CSV fell 4.2% on the week, BFAM dropped 5.6%, and SCI lost 10.2%. ADT's 43% move has compressed the spread between its current price of $9.86 and whatever the market is pricing as deal value, shifting the stock firmly into arbitrage territory. Options positioning has swung with it: the put/call ratio collapsed to 0.58 on Friday from above 1.60 for most of October, nearly four standard deviations below its 20-day average. That is not a vote of confidence in the business; it is arbitrageurs selling puts and calls to harvest the now-narrow premium range.

The lending market is consistent with a stock whose short thesis has been scrambled. Availability is extremely loose, with roughly 6,285% of short interest available to borrow, far above the 52-week trough of 712%. Borrow costs are just 0.54% annually. Short interest is 3.2% of the free float, little changed over the past month and well down from late September. There is no squeeze dynamic yet, despite the deal, because the borrow is easy and the position is not crowded.

The ownership story is where ADT differs most from a standard arbitrage setup. State Farm Mutual Automobile Insurance Company holds a 19.72% Schedule 13D/A stake, up from 18.09% previously, and is classified as an activist holder on ORTEX's 13D register. Those stakes are as-last-disclosed and positions can move without a follow-on filing, but State Farm's trajectory has been consistently upward across three filings since April 2025. BlackRock added shares to reach 10.3% per its August 2026 13G/A, and Vanguard Portfolio Management filed an updated 13G/A on 30 October, lifting its reported stake to 8.46% from 6.01%. That three-way concentration at the top of the register leaves a very small portion of the float available for conventional price discovery.

ORTEX's Index Rebalance Radar puts an 84% probability on ADT's deletion from the Russell 1000 and an 80% probability on removal from the S&P SmallCap 600, with announcements forecast for 24 February 2027 and effective dates estimated around 3 March 2027. The S&P SmallCap 600 deletion would require index trackers to sell an estimated $820 million of stock, equivalent to roughly 10.9 days of normal volume. Past comparable deletions across 87 events saw median moves of negative 4.8% from announcement to effective date. These are ORTEX forecasts, not confirmed index decisions.

The November 3 earnings report arrives inside a stock that has already been repriced by a takeover bid, leaving the quarterly numbers to test whether the deal terms hold and whether any operational surprises are enough to reopen the gap between where the stock trades and where the acquirer has committed to take it.